| Direct Competitor Comparison | |
|---|
| ONTY | GSK | RHHBY | PVT1 | Industry |
|---|
| Market Cap: | 114.43M | 127.52B | 219.62B | N/A | 71.76B |
|---|
| Employees: | 42 | 99,488 | 82,089 | 30,3051 | 450.00 |
|---|
| Qtrly Rev Growth (yoy): | N/A | -0.03 | 0.12 | N/A | 0.27 |
|---|
| Revenue (ttm):
| N/A | 42.21B | 50.83B | 18.34B1 | 13.93B |
|---|
| Gross Margin (ttm): | N/A | 0.71 | 0.75 | N/A | 0.72 |
|---|
| EBITDA (ttm): | -30.23M | 14.49B | 20.10B | N/A | 1.51B |
|---|
| Operating Margin (ttm):
| N/A | 0.28 | 0.34 | N/A | 0.13 |
|---|
| Net Income (ttm): | -21.39M | 6.78B | 10.22B | 1.51B1 | N/A |
|---|
| EPS (ttm): | -0.54 | 2.74 | 2.99 | N/A | 0.61 |
|---|
| P/E (ttm): | N/A | 19.24 | 21.66 | N/A | 18.43 |
|---|
| PEG (5 yr expected): | N/A | 4.19 | 2.31 | N/A | 1.51 |
|---|
| P/S (ttm): | N/A | 3.02 | 4.32 | N/A | 3.64 |
|---|
|
| GSK = GlaxoSmithKline plc | | RHHBY = Roche Holding AG | | Pvt1 = Takeda Pharmaceutical Company Limited | | Industry = Biotechnology | | 1 = As of 2012 |
| Biotechnology Companies Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Amgen Inc. | AMGN | 104.24 | 0.00 | 78.18B | 17.64 |
|---|
| Genentech, Inc. | "Private" |
|---|
| Biogen Idec Inc. | BIIB | 231.33 | 0.00 | 54.91B | 36.71 |
|---|
| Genzyme Corporation | "Private" |
|---|
| Merck Serono S.A. | "Private" |
|---|
| Gilead Sciences Inc. | GILD | 56.47 | 0.00 | 86.14B | 31.62 |
|---|
| MedImmune, L.L.C. | "Private" |
|---|
| Life Technologies Corporation | LIFE | 73.68 | 0.00 | 12.68B | 31.19 |
|---|
| Teva Pharmaceutical Industries Limited | TEVA | 40.21 | 0.00 | 34.26B | 20.07 |
|---|
| Sandoz International GmbH | "Private" |
|---|
|
| Generic Drugmakers Ranked by Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Actavis, Inc. | ACT | 130.20 | 0.00 | 16.63B | N/A |
|---|
| Ranbaxy Laboratories Limited | "Private" |
|---|
| Mylan, Inc. | MYL | 31.23 | 0.00 | 11.90B | 20.86 |
|---|
| Pfizer Inc. | PFE | 28.78 | 0.00 | 204.14B | 13.78 |
|---|
| Johnson & Johnson | JNJ | 88.59 | 0.00 | 248.84B | 24.06 |
|---|
| GlaxoSmithKline plc | GSK | 52.65 | 0.00 | 127.52B | 19.24 |
|---|
| Sanofi | SNY | 55.05 | 0.00 | 145.70B | 27.13 |
|---|
| Novartis AG | NVS | 74.63 | 0.00 | 183.38B | 18.94 |
|---|
| Roche Holding AG | RHHBY | 64.71 | 0.00 | 219.62B | 21.66 |
|---|
| AstraZeneca PLC | AZN | 51.71 | 0.00 | 64.64B | 11.44 |
|---|
|
| Drugmakers Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Abbott Laboratories | ABT | 37.72 | 0.00 | 58.80B | 11.50 |
|---|
| Bristol-Myers Squibb Company | BMY | 44.06 | 0.00 | 72.37B | 49.90 |
|---|
|
| News on Direct Competitors | |
|---|
No Direct Competitor ComparisionCurrency in USD. | |
|
0.12%